Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04625413 · ClinicalTrials.gov registry record · NA
A Patient-centered Communication Tool (UR-GOAL) for Older Patients With Acute Myeloid Leukemia, Their Caregivers, and Their Oncologists
A NA study, sponsored by University of Rochester.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT04625413 is a NA study that has completed, run by University of Rochester. The registered enrollment target is 15 participants.
The verdict
NCT04625413, a NA study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
This is a pilot study to evaluate the usability and feasibility of a patient-centered communication tool (University of Rochester-Geriatric Oncology Assessment for acute myeloid Leukemia or UR-GOAL) among 15 older patients with AML, their caregivers, and oncologists.
Interventions
- BEHAVIORAL Behavioral: UR-GOAL communication tool
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2021-10-23 |
| Est. Completion | 2022-10-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04625413
The ClinicalTrials.gov registry entry for NCT04625413 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Behavioral: UR-GOAL communication tool is the first listed.
NCT04625413 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04625413 about?
NCT04625413 is a clinical study titled "A Patient-centered Communication Tool (UR-GOAL) for Older Patients With Acute Myeloid Leukemia, Their Caregivers, and Their Oncologists". This is a pilot study to evaluate the usability and feasibility of a patient-centered communication tool (University of Rochester-Geriatric Oncology Assessment for acute myeloid Leukemia or UR-GOAL) among 15 older patients with AML, their caregivers, and oncologists.
What is the current status of trial NCT04625413?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2021-10-23. Estimated completion is 2022-10-11.
What interventions are being tested in trial NCT04625413?
The interventions under investigation include: Behavioral: UR-GOAL communication tool (BEHAVIORAL).
Who is sponsoring clinical trial NCT04625413?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.